Dr. Denner should be sitting on the board. He can orchestrate a partnership to sell V in Europe. With an established BP sales force promoting V we’d get sales ramped up. That would pull our stock out of this quagmire. Phase two would be Dr. Denner effectuating that partner to buy us outright. It's not wishful thinking; it's what he does best. When KM took over in August of 2021 our stock was trading at $4.25. During KM's 16 month reign the stock has lost 70% of its value. The buyout won't ever come to pass with KM at the helm. With a limited bankroll and satellite offices in each country sales will never take off, period!